Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Leading Social Media Platforms Unite to Support COVID-19 Vaccine Drive
Collaboration comes as all adults aged 18 and over invited to get a jab Filters […]
More than 30 Million People Vaccinated with Second Dose
More than 30 million people in the UK have been vaccinated with a second dose […]
Sir Richard Sykes Appointed Chair of Vaccine Taskforce
Sir Richard will use his extensive experience in biotechnology and pharmaceuticals to lead the significant […]
Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics
Life science industry leaders are joining forces with governments to step up collective efforts to […]
New UK Strategy Sets out Ambition to Be World Leaders in Organ Donation and Transplantation
Increasing consent rates for organ donation and making the most of donated organs for transplant […]
Eddie Gray Appointed Chair of Antivirals Taskforce
The UK government has appointed Eddie Gray as the new chair of the Antivirals Taskforce. […]
NHS Treats First Patient with the ‘World’s Most Expensive Drug’
A five-month old baby has become the first patient to receive a potentially life-saving drug […]
Janssen single dose Covid-19 vaccine authorised by UK medicines regulator
Janssen’s single-dose COVID-19 vaccine has been authorised for use by the UK medicines regulator. The […]
60 Million Doses of Covid-19 Vaccine Administered in UK
Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the […]
Next Phase of Vaccine Roll-Out
The UK is moving into the next phase of the COVID-19 vaccine programme as the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more